• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痰液颜色作为 COPD 急性加重期细菌标志物的研究:系统评价和荟萃分析方案。

Sputum colour as a marker for bacteria in acute exacerbations of COPD: protocol for a systematic review and meta-analysis.

机构信息

Port Elizabeth Hospital Complex, Port Elizabeth, South Africa.

Livingstone Tertiary Hospital, Stanford Road, Port Elizabeth, South Africa.

出版信息

Syst Rev. 2021 Jul 27;10(1):211. doi: 10.1186/s13643-021-01767-6.

DOI:10.1186/s13643-021-01767-6
PMID:34315541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8317370/
Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) is a major cause of years of life lost globally. Acute exacerbations of COPD (AECOPD) drive disease progression, reduce quality of life and are a source of mortality in COPD. Approximately 50% of AECOPD are due to bacterial infections. Diagnosing bacterial infection as the aetiology of AECOPD however remains challenging as investigations are limited by practicality, accuracy and expense. Clinicians have traditionally used sputum colour as a marker of bacterial infection in AECOPD, despite the lack of high-quality evidence for this practice. The aim of this systematic review and meta-analysis is to determine the diagnostic accuracy of sputum colour in the diagnosis of bacterial causes of AECOPD.

METHODS

Articles will be searched for in electronic databases (MEDLINE, Google Scholar Scopus, Web of Science, Africa-Wide, CINAHL and Health Source Nursing Academy) and we will conduct a review of citation indexes and the grey literature. Two reviewers will independently conduct study selection, against pre-defined eligibility criteria, data extraction and quality assessment of included articles using the QUADAS-2 tool. We will perform a meta-analysis using a bivariate logistic regression model with random effects. We will explore heterogeneity through the visual examination of the forest plots of sensitivities and specificities and through the inclusion of possible sources of heterogeneity as covariates in a meta-regression model if sufficient studies are included in the analysis. We also perform a sensitivity analysis to explore the effect of study quality on our findings. The results of this review will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis statement and will be submitted for peer-review and publication.

DISCUSSION

The findings of this review will assist clinicians in diagnosing the aetiology of AECOPD and may have important implications for decision making in resource-limited settings, as well as for antimicrobial stewardship.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO CRD42019141498.

摘要

背景

慢性阻塞性肺疾病(COPD)是全球范围内导致多年生命损失的主要原因。COPD 的急性加重(AECOPD)会导致疾病进展、降低生活质量,并且是 COPD 患者死亡的一个原因。大约 50%的 AECOPD 是由细菌感染引起的。然而,由于检查受到实用性、准确性和费用的限制,诊断 AECOPD 中细菌感染的病因仍然具有挑战性。临床医生传统上使用痰液颜色作为 AECOPD 中细菌感染的标志物,尽管这种做法缺乏高质量的证据。本系统评价和荟萃分析的目的是确定痰液颜色在诊断 AECOPD 中细菌病因方面的诊断准确性。

方法

将在电子数据库(MEDLINE、Google Scholar Scopus、Web of Science、Africa-Wide、CINAHL 和 Health Source Nursing Academy)中搜索文章,并对引文索引和灰色文献进行综述。两名审查员将根据预先确定的纳入标准,独立进行研究选择、数据提取和纳入文章的质量评估,使用 QUADAS-2 工具。我们将使用二元逻辑回归模型进行荟萃分析,采用随机效应。如果分析中包含足够的研究,我们将通过视觉检查敏感性和特异性的森林图以及将可能的异源因素作为协变量纳入荟萃回归模型来探索异质性。我们还进行敏感性分析,以探讨研究质量对我们发现的影响。本综述的结果将按照系统评价和荟萃分析的首选报告项目进行报告,并将提交同行评审和发表。

讨论

本综述的结果将有助于临床医生诊断 AECOPD 的病因,并可能对资源有限环境中的决策制定以及抗菌药物管理产生重要影响。

系统评价注册

PROSPERO CRD42019141498。

相似文献

1
Sputum colour as a marker for bacteria in acute exacerbations of COPD: protocol for a systematic review and meta-analysis.痰液颜色作为 COPD 急性加重期细菌标志物的研究:系统评价和荟萃分析方案。
Syst Rev. 2021 Jul 27;10(1):211. doi: 10.1186/s13643-021-01767-6.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Sputum Color as a Marker for Bacteria in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.痰液颜色作为慢性阻塞性肺疾病急性加重期细菌感染的标志物:一项系统评价与荟萃分析
Ann Am Thorac Soc. 2023 May;20(5):738-748. doi: 10.1513/AnnalsATS.202204-319OC.
4
Chronic obstructive pulmonary disease exacerbation purulence status and its association with pulmonary embolism: protocol for a systematic review with meta-analysis.慢性阻塞性肺疾病加重期脓性状态及其与肺栓塞的相关性:系统评价与荟萃分析的方案。
BMJ Open. 2024 Jun 19;14(6):e085328. doi: 10.1136/bmjopen-2024-085328.
5
Validation of acute exacerbation of chronic obstructive pulmonary disease (COPD) recording in electronic health records: a systematic review protocol.电子健康记录中慢性阻塞性肺疾病(COPD)急性加重记录验证的系统评价方案。
BMJ Open. 2020 Feb 27;10(2):e032467. doi: 10.1136/bmjopen-2019-032467.
6
Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis.生物标志物指导慢性阻塞性肺疾病急性加重(AECOPD)抗生素使用:系统评价和荟萃分析。
BMC Pulm Med. 2022 May 13;22(1):194. doi: 10.1186/s12890-022-01958-4.
7
Mapping of modifiable barriers and facilitators with interdisciplinary chronic obstructive pulmonary disease (COPD) guidelines concordance within hospitals to the Theoretical Domains Framework: a mixed methods systematic review protocol.医院内可修改障碍和促进因素与跨学科慢性阻塞性肺疾病(COPD)指南一致性的映射到理论领域框架:混合方法系统评价方案。
BMJ Open. 2020 Jul 20;10(7):e036060. doi: 10.1136/bmjopen-2019-036060.
8
Levels of immunoglobulin isotypes in serum and respiratory samples of patients with chronic obstructive pulmonary disease: protocol for a systematic review and meta-analysis.血清和慢性阻塞性肺疾病患者呼吸道样本中免疫球蛋白同种型水平:系统评价和荟萃分析方案。
BMJ Open. 2023 Feb 9;13(2):e064307. doi: 10.1136/bmjopen-2022-064307.
9
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.C 反应蛋白即时检测用于安全减少慢性阻塞性肺疾病急性加重期抗生素使用的研究:PACE RCT。
Health Technol Assess. 2020 Mar;24(15):1-108. doi: 10.3310/hta24150.
10
Remote Patient Monitoring and Machine Learning in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Dual Systematic Literature Review and Narrative Synthesis.远程患者监测和慢性阻塞性肺疾病急性加重期的机器学习:双重系统文献回顾和叙述性综合。
J Med Internet Res. 2024 Sep 9;26:e52143. doi: 10.2196/52143.

引用本文的文献

1
Chlamydia psittaci Pneumonia: Diagnosis, Treatment, and Challenges in the Context of COVID-19.鹦鹉热衣原体肺炎:在 COVID-19 背景下的诊断、治疗和挑战。
Am J Case Rep. 2024 May 8;25:e942921. doi: 10.12659/AJCR.942921.
2
Effect Analysis of Lung Rehabilitation Training in 5A Nursing Mode for Elderly Patients with COPD Based on X-Ray.基于 X 光的 5A 护理模式对老年 COPD 患者肺康复训练的效果分析。
Comput Math Methods Med. 2022 Jun 13;2022:1963426. doi: 10.1155/2022/1963426. eCollection 2022.

本文引用的文献

1
PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews.PRISMA-S:用于在系统评价中报告文献检索的 PRISMA 声明的扩展。
Syst Rev. 2021 Jan 26;10(1):39. doi: 10.1186/s13643-020-01542-z.
2
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.系统评价中不进行荟萃分析的综合 (SWiM):报告指南。
BMJ. 2020 Jan 16;368:l6890. doi: 10.1136/bmj.l6890.
3
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
4
Antibiotics for exacerbations of chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病加重期的抗生素
Cochrane Database Syst Rev. 2018 Oct 29;10(10):CD010257. doi: 10.1002/14651858.CD010257.pub2.
5
Antibiotics for exacerbations of asthma.用于哮喘加重期的抗生素
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2.
6
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.诊断测试准确性研究的系统评价和荟萃分析的首选报告项目:PRISMA-DTA 声明。
JAMA. 2018 Jan 23;319(4):388-396. doi: 10.1001/jama.2017.19163.
7
Antibiotics for COPD exacerbations.用于慢性阻塞性肺疾病急性加重期的抗生素
Lancet Respir Med. 2017 Jun;5(6):461-462. doi: 10.1016/S2213-2600(17)30166-2. Epub 2017 May 5.
8
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis.降钙素原指导慢性阻塞性肺疾病急性加重期抗生素使用的荟萃分析
Eur Respir Rev. 2017 Jan 31;26(143). doi: 10.1183/16000617.0073-2016. Print 2017 Jan.
9
Rayyan-a web and mobile app for systematic reviews.Rayyan——一款用于系统评价的网络和移动应用程序。
Syst Rev. 2016 Dec 5;5(1):210. doi: 10.1186/s13643-016-0384-4.
10
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.系统评价和荟萃分析议定书的首选报告项目(PRISMA-P)2015:详细说明和解释。
BMJ. 2015 Jan 2;350:g7647. doi: 10.1136/bmj.g7647.